Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Safety topic
No spam. Unsubscribe anytime.
House approves testing for psychotropic drugs after mass shootings amid sharp debate
Summary
The House passed SB 2088, which requires expanded post-incident testing for psychotropic drugs in mass-shooting deaths; supporters said results could inform policy, while critics called the bill a "false solution" that does not address access to weapons.
Chairlady Littleton described SB 2088 as expanding the definition of a "mass shooting" for purposes of requiring that the decedent's blood be tested for psychotropic drugs and allowing officers with probable cause to seek consent for blood or urine testing to determine the presence of therapeutic psychotropic drugs. She said the results would be sent to the University of Tennessee Health Science Center for analysis.
Representative Jones challenged the premise during floor debate, saying the bill "does nothing to actually address the cause of mass shootings" and calling it a "false solution" rooted in "faulty logic and faulty assessment." Littleton answered that the intent is to determine whether psychotropic drugs were present and whether dosing or prescription issues might be relevant.
Representative Rudd and others argued some mass-shooting perpetrators have been under psychiatric care or prescriptions; supporters said data could help understanding. Critics answered that other countries with access to similar medications do not see equivalent mass-shooting rates and that focusing on drugs risks distracting from other drivers such as weapon access.
Vote: The House recorded 76 ayes and 21 nays and the Speaker declared SB 2088 passed. The motion to reconsider was tabled.
